2-151642629-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001164507.2(NEB):​c.8318G>A​(p.Arg2773Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0257 in 1,613,648 control chromosomes in the GnomAD database, including 644 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2773W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.019 ( 51 hom., cov: 33)
Exomes 𝑓: 0.026 ( 593 hom. )

Consequence

NEB
NM_001164507.2 missense

Scores

3
4
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 4.95
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036732256).
BP6
Variant 2-151642629-C-T is Benign according to our data. Variant chr2-151642629-C-T is described in ClinVar as [Benign]. Clinvar id is 129758.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-151642629-C-T is described in Lovd as [Benign]. Variant chr2-151642629-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0188 (2869/152280) while in subpopulation SAS AF= 0.0453 (219/4830). AF 95% confidence interval is 0.0404. There are 51 homozygotes in gnomad4. There are 1393 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 51 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NEBNM_001164507.2 linkuse as main transcriptc.8318G>A p.Arg2773Gln missense_variant 60/182 ENST00000427231.7
NEBNM_001164508.2 linkuse as main transcriptc.8318G>A p.Arg2773Gln missense_variant 60/182 ENST00000397345.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NEBENST00000397345.8 linkuse as main transcriptc.8318G>A p.Arg2773Gln missense_variant 60/1825 NM_001164508.2 P5P20929-2
NEBENST00000427231.7 linkuse as main transcriptc.8318G>A p.Arg2773Gln missense_variant 60/1825 NM_001164507.2 A2P20929-3
NEBENST00000409198.5 linkuse as main transcriptc.8318G>A p.Arg2773Gln missense_variant 60/1505 P20929-4

Frequencies

GnomAD3 genomes
AF:
0.0188
AC:
2865
AN:
152162
Hom.:
51
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00500
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0143
Gnomad ASJ
AF:
0.0458
Gnomad EAS
AF:
0.0110
Gnomad SAS
AF:
0.0445
Gnomad FIN
AF:
0.0150
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0261
Gnomad OTH
AF:
0.0215
GnomAD3 exomes
AF:
0.0236
AC:
5875
AN:
248938
Hom.:
95
AF XY:
0.0252
AC XY:
3400
AN XY:
135044
show subpopulations
Gnomad AFR exome
AF:
0.00497
Gnomad AMR exome
AF:
0.00791
Gnomad ASJ exome
AF:
0.0494
Gnomad EAS exome
AF:
0.0135
Gnomad SAS exome
AF:
0.0463
Gnomad FIN exome
AF:
0.0158
Gnomad NFE exome
AF:
0.0257
Gnomad OTH exome
AF:
0.0215
GnomAD4 exome
AF:
0.0264
AC:
38538
AN:
1461368
Hom.:
593
Cov.:
31
AF XY:
0.0271
AC XY:
19710
AN XY:
726954
show subpopulations
Gnomad4 AFR exome
AF:
0.00412
Gnomad4 AMR exome
AF:
0.00863
Gnomad4 ASJ exome
AF:
0.0499
Gnomad4 EAS exome
AF:
0.00771
Gnomad4 SAS exome
AF:
0.0478
Gnomad4 FIN exome
AF:
0.0155
Gnomad4 NFE exome
AF:
0.0267
Gnomad4 OTH exome
AF:
0.0277
GnomAD4 genome
AF:
0.0188
AC:
2869
AN:
152280
Hom.:
51
Cov.:
33
AF XY:
0.0187
AC XY:
1393
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.00498
Gnomad4 AMR
AF:
0.0143
Gnomad4 ASJ
AF:
0.0458
Gnomad4 EAS
AF:
0.0108
Gnomad4 SAS
AF:
0.0453
Gnomad4 FIN
AF:
0.0150
Gnomad4 NFE
AF:
0.0261
Gnomad4 OTH
AF:
0.0213
Alfa
AF:
0.0254
Hom.:
81
Bravo
AF:
0.0170
TwinsUK
AF:
0.0278
AC:
103
ALSPAC
AF:
0.0265
AC:
102
ESP6500AA
AF:
0.00558
AC:
21
ESP6500EA
AF:
0.0285
AC:
234
ExAC
AF:
0.0235
AC:
2837
Asia WGS
AF:
0.0380
AC:
132
AN:
3478
EpiCase
AF:
0.0257
EpiControl
AF:
0.0278

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015p.Arg2773Gln in exon 60 of NEB: This variant is not expected to have clinical si gnificance because it has been identified in 2.8% (234/8218) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs35974308). -
Benign, criteria provided, single submitterclinical testingGeneDxMar 12, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsOct 19, 2020- -
Nemaline myopathy 2 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 24, 2017Variant summary: The NEB c.8318G>A (p.Arg2773Gln) variant involves the alteration of a conserved nucleotide and 3/4 in silico tools (SNPs&GO not captured here due to low reliability index) predict a damaging outcome. This variant was found in 2834/120142 control chromosomes (37 homozygotes) from ExAC at a frequency of 0.0235888, which is approximately 7 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), strongly supporting that this variant is likely a benign polymorphism. The variant is more common in East Asian sub-population with allele frequency of 4.5% (751/16334 chromosomes). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as "likely benign/benign." Therefore, the variant of interest has been classified as Benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.038
.;.;T;.;T;.;.
Eigen
Pathogenic
0.71
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;.;.
MetaRNN
Benign
0.0037
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.7
H;H;.;H;H;H;H
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.3
N;N;.;N;N;.;.
REVEL
Benign
0.27
Sift
Benign
0.14
T;D;.;D;T;.;.
Sift4G
Uncertain
0.0070
D;D;D;D;D;D;D
Polyphen
1.0
.;.;.;.;D;.;.
Vest4
0.70
MPC
0.36
ClinPred
0.099
T
GERP RS
6.2
Varity_R
0.22
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35974308; hg19: chr2-152499143; COSMIC: COSV51417557; API